# A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults

> clinical trial · VERIFIED · 2026-07-28

Status: RECRUITING · Sponsor: Ipsen · Condition: Episodic Migraine

- Company: Ipsen
- Sector: therapeutics
- Primary source: https://clinicaltrials.gov/study/NCT06625060

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.